<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01330771</url>
  </required_header>
  <id_info>
    <org_study_id>FER-GON-2004-01</org_study_id>
    <nct_id>NCT01330771</nct_id>
  </id_info>
  <brief_title>Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP</brief_title>
  <official_title>Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP Within a Protocol of Controlled Ovarian Hyperstimulation in IVF in Normoresponders Women Undergoing Downregulation With GnRH Antagonist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ferring SAU</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ferring Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effectiveness of a protocol of ovarian hyperstimulation combining urinary
      gonadotrophins + recombinant gonadotrophins, to achieve clinical pregnancy in females
      undergoing IVF.

      Study hypothesis: to assess the effectiveness of protocols combining urinary gonadotrophins +
      recombinant gonadotrophins
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical pregnancy rate</measure>
    <time_frame>16 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Sterility</condition>
  <arm_group>
    <arm_group_label>hMG-HP/r-FSH</arm_group_label>
    <description>Patients with a condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hMG-HP/r-FSH</intervention_name>
    <arm_group_label>hMG-HP/r-FSH</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Females affected by sterility able to undergo IVF
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women aged 18-38 years

          -  Body mass index (BMI) between 18 and 30

          -  Women classified as normogonadotrophin patients. Not more than 3 previous cycles of
             ART (assisted reproductive technology)

          -  Testosterona, FSH (follicle-stimulating hormone), LH (luteinizing hormone) and
             Prolactin serum levels during the early folicular phase (days 2-4 of the cycle) within
             the laboratory normal range

          -  No administration of clomiphen citrate or gonadotropins during the month prior to the
             start of the study

        Exclusion Criteria:

          -  Failure in previous cycles of assisted reproduction IVF/ICSI (in-vitro
             fertilisation/intracytoplasmic sperm injection)

          -  Seminal samples not apt for IVF-ICSI (according to the criteria of each center).
             Evidence of significant bacterial infection in the seminogram of the couple in the
             preceding 6 months

          -  Data suggestive of possible ovarian failure

          -  Antecedents of severe ovarian hyperstimulation syndrome (OHSS)

          -  Important systemic disease

          -  Pregnancy or contraindication to pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Development Support</last_name>
    <role>Study Director</role>
    <affiliation>Ferring Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Investigational site</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2011</study_first_submitted>
  <study_first_submitted_qc>April 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2011</study_first_posted>
  <last_update_submitted>April 6, 2011</last_update_submitted>
  <last_update_submitted_qc>April 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2011</last_update_posted>
  <responsible_party>
    <name_title>Clinical Development Support</name_title>
    <organization>Ferring Pharmaceuticals</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

